We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.7B
AUM Growth
+$1.52B
Cap. Flow
+$861M
Cap. Flow %
2.55%
Top 10 Hldgs %
14.52%
Holding
3,141
New
144
Increased
1,491
Reduced
1,301
Closed
155

Sector Composition

Rank Sector Weight
1 Healthcare 14.29%
2 Financials 14.18%
3 Technology 13.8%
4 Industrials 10.4%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
26
Philip Morris
PM
$301B
$226M 0.67%
2,217,395
+175,985
+9% +$17.6M
UNH icon
27
UnitedHealth
UNH
$382B
$217M 0.64%
1,534,849
+49,127
+3% +$6.55M
IBM icon
28
IBM
IBM
$202B
$215M 0.64%
1,480,049
+45,336
+3% +$6.49M
V icon
29
Visa
V
$677B
$211M 0.63%
2,849,265
+56,101
+2% +$4.39M
BAC icon
30
Bank of America
BAC
$435B
$208M 0.62%
15,710,418
+778,497
+5% +$10.9M
ORCL icon
31
Oracle
ORCL
$331B
$203M 0.6%
4,950,028
+117,334
+2% +$4.69M
C icon
32
Citigroup
C
$222B
$189M 0.56%
4,458,602
+200,821
+5% +$8.88M
AMGN icon
33
Amgen
AMGN
$203B
$187M 0.55%
1,228,754
+45,400
+4% +$7.06M
MDT icon
34
Medtronic
MDT
$107B
$180M 0.53%
2,073,487
+122,326
+6% +$9.89M
MO icon
35
Altria Group
MO
$122B
$178M 0.53%
2,587,024
+91,152
+4% +$5.84M
MMM icon
36
3M
MMM
$89B
$176M 0.52%
1,203,566
+8,763
+0.7% +$1.24M
WMT icon
37
Walmart Inc
WMT
$871B
$174M 0.52%
7,142,391
+304,254
+4% +$7.04M
GILD icon
38
Gilead Sciences
GILD
$161B
$173M 0.51%
2,072,802
-10,650
-0.5% -$945K
BMY icon
39
Bristol-Myers Squibb
BMY
$127B
$173M 0.51%
2,349,064
+89,086
+4% +$6.29M
SLB icon
40
SLB Ltd
SLB
$77.8B
$172M 0.51%
2,170,781
+321,123
+17% +$24.6M
MCD icon
41
McDonald's
MCD
$188B
$171M 0.51%
1,416,908
-7,785
-0.5% -$975K
CVS icon
42
CVS Health
CVS
$137B
$163M 0.48%
1,704,271
+3,877
+0.2% +$386K
ABBV icon
43
AbbVie
ABBV
$458B
$141M 0.42%
2,281,363
+81,773
+4% +$4.98M
MA icon
44
Mastercard
MA
$477B
$133M 0.39%
1,513,145
+22,864
+2% +$2.18M
QCOM icon
45
Qualcomm
QCOM
$176B
$130M 0.38%
2,424,495
+100,428
+4% +$5.29M
HON icon
46
Honeywell
HON
$77.1B
$127M 0.38%
1,214,282
+28,140
+2% +$2.89M
SBUX icon
47
Starbucks
SBUX
$118B
$125M 0.37%
2,192,566
+8,958
+0.4% +$509K
AGN
48
DELISTED
Allergan plc
AGN
$124M 0.37%
537,997
+34,451
+7% +$7.94M
RTX icon
49
RTX Corp
RTX
$287B
$121M 0.36%
1,878,076
+27,597
+1% +$1.77M
CELG
50
DELISTED
Celgene Corp
CELG
$117M 0.35%
1,190,533
+41,312
+4% +$4.27M

Similar funds

RhumbLine Advisers's Q2 2016 Portfolio in Review

As of Q2 2016, RhumbLine Advisers held 3,141 positions worth $33.7B, up 4.7% from $32.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q2 2016 filing shows 144 new, 1,491 increased, 1,301 reduced and 155 closed positions. Its largest new stake was S&P Global: 401,386 shares worth $43.1M. The largest sale was TIME WARNER CABLE INC NEW COM STK, an estimated $86.8M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • RhumbLine Advisers's largest Q2 2016 buy was S&P Global: 401,386 shares worth $43.1M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2016, an estimated $33.4M increase.
  • RhumbLine Advisers's biggest Q2 2016 reduction was Coca-Cola Europacific Partners, cutting an estimated $16.1M.
  • RhumbLine Advisers fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $86.8M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $33.7B portfolio in Q2 2016.
  • RhumbLine Advisers opened 144 new positions and closed 155 in Q2 2016.
  • RhumbLine Advisers's portfolio value rose 4.7% quarter-over-quarter to $33.7B.

Based on RhumbLine Advisers's 13F filing for Q2 2016, filed 11 Aug 2016.